Firuglipel

• CAT Number: I006799
• CAS Number: 1371591-51-3
• Molecular Formula: C25H26FN3O5
• Molecular Weight: 467.49
• Purity: ≥95%
• Synonyms: Firuglipel.;4-(5-{(1R)-1-[4-(cyclopropanecarbonyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluoro-N-[(2R)-1-hydroxypropan-2-yl]benzamide
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO
• Storage: 0 - 4°C for short term or -20 °C for long term
• IUPAC Name: 4-[5-[(1R)-1-[4-(cyclopropanecarbonyl)phenoxy]propyl]-1,2,4-oxadiazol-3-yl]-2-fluoro-N-[(2R)-1-hydroxypropan-2-yl]benzamide
• InChI: InChI=1S/C25H26FN3O5/c1-3-21(33-18-9-6-16(7-10-18)22(31)15-4-5-15)25-28-23(29-34-25)17-8-11-19(20(26)12-17)24(32)27-14(2)13-30/h6-12,14-15,21,30H,3-5,13H2,1-2H3,(H,27,32)/t14-,21-/m1/s1
• InChIKey: LRXRIKVDAVVQCP-SPLOXXLWSA-N
• SMILES: CC[C@H](C1=NC(=NO1)C2=CC(=C(C=C2)C(=O)N[C@H](C)CO)F)OC3=CC=C(C=C3)C(=O)C4CC4

Firuglipel（Cat No.:I006799）is a synthetic compound that functions as an antagonist of the 5-HT2A receptor, a subtype of serotonin receptor involved in mood regulation, perception, and cognition. By blocking this receptor, Firuglipel has shown potential for therapeutic use in psychiatric disorders such as schizophrenia and depression, where serotonin dysregulation is implicated. Additionally, it may have applications in modulating cognitive function and alleviating symptoms of anxiety or psychosis. While still under investigation, Firuglipel represents a promising tool in exploring serotonin receptor-based therapies for mood and cognitive disorders.